ImmuPharma PLC Sustainability Reports
ImmuPharma PLC is a pharmaceutical company focused on developing innovative drugs for serious medical conditions, including autoimmune diseases and cancer.
Sector: Health Care
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
ISIN: GB0033711010
16 reports from 2006 to 2025
- ImmuPharma PLC 2025 Report and Consolidated Financial Statements
- ImmuPharma PLC 2024 Report and Consolidated Financial Statements
- ImmuPharma PLC 2023 Report and Consolidated Financial Statements
- ImmuPharma PLC 2022 Report and Consolidated Financial Statements
- ImmuPharma PLC 2021 Report and Consolidated Financial Statements
Company Profile
ImmuPharma PLC
ImmuPharma PLC is a pharmaceutical company focused on developing innovative drugs for serious medical conditions, including autoimmune diseases and cancer.
Reports